Title: Research Communications of the 27(th) ECVIM-CA Congress: Intercontinental, Saint Julian's, Malta, 14th to 16th September 2017 Document date: 2017_11_7
ID: roslkxeq_626
Snippet: Disclosures: Disclosures to report. The research was partly supported by Bayer Hungary. Symmetric dimethylarginine (SDMA) has been proposed as a sensitive and specific renal biomarker whose concentration increases earlier than serum creatinine (SCr) as glomerular filtration rate decreases. SDMA is a promising parameter in the diagnosis and management of chronic kidney disease (CKD) and it is included into the International Renal Interest Society .....
Document: Disclosures: Disclosures to report. The research was partly supported by Bayer Hungary. Symmetric dimethylarginine (SDMA) has been proposed as a sensitive and specific renal biomarker whose concentration increases earlier than serum creatinine (SCr) as glomerular filtration rate decreases. SDMA is a promising parameter in the diagnosis and management of chronic kidney disease (CKD) and it is included into the International Renal Interest Society (IRIS) guidelines.
Search related documents:
Co phrase search for related documents- glomerular filtration rate decrease and renal biomarker: 1
- glomerular filtration rate decrease and SDMA symmetric dimethylarginine: 1
- kidney disease and management diagnosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- kidney disease and renal biomarker: 1, 2, 3, 4, 5, 6, 7, 8
- kidney disease and SCr serum creatinine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- kidney disease and SDMA symmetric dimethylarginine: 1, 2, 3, 4, 5, 6, 7, 8, 9
- kidney disease and serum creatinine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- kidney disease and symmetric dimethylarginine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- management diagnosis and serum creatinine: 1, 2, 3, 4, 5
- renal biomarker and SCr serum creatinine: 1, 2, 3
- renal biomarker and SDMA symmetric dimethylarginine: 1, 2, 3, 4, 5
- renal biomarker and serum creatinine: 1, 2, 3, 4, 5, 6, 7, 8
- renal biomarker and symmetric dimethylarginine: 1, 2, 3, 4, 5, 6
- SCr serum creatinine and SDMA symmetric dimethylarginine: 1, 2, 3
- SCr serum creatinine and serum creatinine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52
- SCr serum creatinine and symmetric dimethylarginine: 1, 2, 3, 4
- SDMA symmetric dimethylarginine and serum creatinine: 1, 2, 3, 4, 5, 6, 7, 8, 9
- SDMA symmetric dimethylarginine and symmetric dimethylarginine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- serum creatinine and symmetric dimethylarginine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
Co phrase search for related documents, hyperlinks ordered by date